SLL: Clinical Trials

1 trial for SLL, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow SLL: new trials by email Literature Review of SLL trials Research Report on SLL

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
veltuzumab - NHL, Lymphoma, Non-Hodgkin
Phase 1 / Phase 2CompletedGilead Sciences322008-01-012021-08-16

Narrower conditions

Dendritic Cell Sarcoma, Interdigitating (1)  ·  Leukemia (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Prolymphocytic (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Non-Hodgkin (1)

Broader conditions

Chronic Disease (1)  ·  Disease Attributes (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Histiocytic Disorders, Malignant (1)  ·  Histiocytosis (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia, B-Cell (1)  ·  Leukemia, Lymphoid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

veltuzumab (1)

Sponsors

Gilead Sciences (1)

Countries

United States (1)

Top investigators

William Wegener, MD, PhD (1)

Results publications

PMID 21173095, PMID 26389849